Skip to main content
. Author manuscript; available in PMC: 2015 Sep 8.
Published in final edited form as: Cancer Chemother Pharmacol. 2011 Jun 5;69(1):185–194. doi: 10.1007/s00280-011-1684-y

Fig. 2.

Fig. 2

a Dose response of perifosine in 786-O. Cells were treated with single-agent perifosine at indicated doses and harvested at 24 h. Time courses following perifosine treatment in (b) 786-O (VHL mutant) and (c) CAKI-1 (VHL wt). Cells were treated with 5 mM perifosine and harvested at indicated time points